Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Summary:
- Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
- A moving average of Short volume ratio is at a recent 2 week high. A high short volume ratio indicate selling presures.
- MACD is crossing MACD signal line at 2.6. MACD crossing signal line is bullish signal.
| MarketCap | 307.2B |
|---|---|
| PE Ratio | 51.6 |
| PEG Ratio | 1.9 |
| P/B | 28.8 |
| P/S (ttm) | 8.2 |
| Earning Growth (QoQ) | -7% |
| Revenue Growth (QoQ) | |
| Short % | 1% |
| Held by Institutions % | 84% |
| 1 Day Vol Adjusted Return | -0.8 |
| 1 Month Vol Adjusted Return | 3.0 |
| 3 Month Vol Adjusted Return | -0.2 |
| 6 Month Vol Adjusted Return | 6.7 |
| 20 Days SMA Price ZScore | 1.3 |
| 50 Days SMA Price ZScore | 0.9 |
| 12 -26 Days PPO | 0.8 |
| 1 Month Average Short Volume Ratio | 50.1 |
| 1 Day Volume Change ZScore | 0.0 |
| 1 Month Daily Vol | 2.5 |
Stock news
Leading drug company Eli Lilly broke above its buy point of 335.43 from a flat base on Wednesday. Trading surged to almost twice the usual volume as investors bought shares of the leading biopharmaceutical company. Shares also surged in sympathy after Biogen's successful trial for a drug to treat Alzheimer's, announced on Thursday.
The major indexes fell, with the S&P 500 breaking below bear market lows. Biogen soared on an Alzheimer's drug while Nike dived.
In this article, we discuss the top 10 stock picks of Dmitry Balyasny’s hedge fund. If you want to skip our detailed analysis of Balyasny’s investment philosophy and performance, go directly to the Top 5 Stock Picks of Dmitry Balyasny’s Hedge Fund. Dmitry Balyasny is the managing partner and chief investment officer of Balyasny Asset […]
The success of Biogen (BIIB)-Eisai's AD candidate in a big phase III study makes investors optimistic about the prospects of other AD candidates as well.
Dow Jones futures fell as Treasury yields rebounded, signaling Wednesday's rally may be short-lived. Eli Lilly leads some bullish stocks.
The major indexes rebounded as Treasury yields tumbled from 4% as the Bank of England resumed bond buying. Eli Lilly led stocks showing bullish action. Here's what to do now.
In this article, we discuss 11 best dividend-paying stocks to buy now. You can skip our detailed analysis of dividend stocks and their returns, and go directly to read 5 Best Dividend Paying Stocks To Buy Now. Dividend companies are gaining ground among investors this year as they navigate the rocky market. In times of financial […]
Biogen stock catapulted Wednesday — bringing shares of other Alzheimer's plays with it — after its experimental treatment succeeded in a test.
Editor's note: This profile is part of CBJ's inaugural Power 100, which highlights key players in the Charlotte region's next phase of growth with a focus on jobs, economic diversification and innovation. A year ago, pharmaceutical giant Eli Lilly and Co. did not have a presence in the Charlotte region. Now, the company’s efforts here, led by David Ricks as chairman and CEO, are expected to play a major role in the future of the Charlotte region’s economy.